This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment of minimal change disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The management of minimal change nephropathy involves:

  • diuretics should be used with care, avoiding hyponatraemia and a further drop in intravascular volume
  • salt-poor albumin is used in a few patients
  • restrict fluid intake while the patient is oedematous
  • prophylactic penicillin if oedematous
  • 90% of children respond to steroids within 8 weeks

Immunosuppression (cyclophosphomide, ciclosporin, ritixumab) may be indicated if there are early/frequent relapses or steroid side-effects/dependence.

A remission that lasts three years is usually permanent.

With respect to interventions for minimal change disease in adults a systematic review concluded (1):

  • concludes calcineurin inhibitors and mycophenolate probably make little or no difference to rate of remission, partial remission or relapse vs prednisolone, but calcineurin inhibitors may reduce adverse effects

Reference:

  • Azukaitis K, Palmer SC, Strippoli GFM, Hodson EM. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD001537. DOI: 10.1002/14651858.CD001537.pub5

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.